Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients

Saved in:
Bibliographic Details
Title: Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients
Authors: Tunbridge, Matthew1 (AUTHOR) Matthew.Tunbridge@sa.gov.au, Perkins, Griffith B.2,3 (AUTHOR), Singer, Julian4,5 (AUTHOR), Salehi, Tania1 (AUTHOR), Ying, Tracey4,5 (AUTHOR), Grubor-Bauk, Branka6,7 (AUTHOR), Barry, Simon6,8,9 (AUTHOR), Sim, Beatrice1 (AUTHOR), Hissaria, Pravin10 (AUTHOR), Chadban, Steven J.4,5 (AUTHOR), Coates, P. Toby1,6 (AUTHOR)
Source: Trials. 9/15/2022, Vol. 23 Issue 1, p1-12. 12p. 1 Diagram, 1 Chart.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17456215
DOI:10.1186/s13063-022-06634-w